Insulin Degludec
Indication
Type 2 diabetes
Green (Restricted)
Brand:
Tresiba®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
Must be commenced by a healthcare professional who is appropriately trained and experienced in the initiation of insulin
Specialists may exceptionally consider initiating insulin degludec if:
-
Patient is experiencing poor glycaemic control or recurrent hypoglycaemic episodes with their existing long-acting insulin analogue or
-
Patient is unable to take basal insulin at the same time each day
Recommendation
LSCMMG Recommendation:
Green (Restricted)
Reason for decision:
Suitable for initiation in primary care in line with restrictions
Supporting documents: